Emerging biotechnologies, strategic collaborations, and growing focus on personalized and regenerative medicine are accelerating the next wave of gene therapy innovation.Austin, Nov. 05, 2025 (GLOBE ...

A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate ...

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...

A lthough still in its early days, CRISPR has already been called the most powerful scientific tool of the century. Using ...

The scientist responsible for creating the world’s first “genetically modified” babies has just been sentenced to three years ...

We have the tech to make designer babies but we are not ready for it yet. Read more at straitstimes.com. Read more at straitstimes.com.

Among those groups is one led by James Voss, an immunologist at Scripps Research in La Jolla, California, who plans to use the mice to advance his work on targeted HIV therapies. Voss and his team ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

The practice of "bluetoothing" or "flashblooding" has alarmed global public health experts who note that injecting a drug user's blood for a quick high is risky on many levels. Plus, surgeons perform ...

Researchers conducted a retrospective, multinational study across 15 European treatment centers to assess the efficacy and tolerability of DTG/3TC vs BIC/TAF/FTC as first‑line therapy in ...

Introduction: Pregnant or parenting adolescent girls and young women (PPYW) are at greater risk of sexual exposure to HIV than their peers, yet tailored HIV prevention efforts for PPYW remain limited.